802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study.
Saved in:
| Title: | 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study. |
|---|---|
| Authors: | Brunelli, M.1 (AUTHOR), Buti, S.2 (AUTHOR), Rebuzzi, S.E.3 (AUTHOR), Milella, M.4 (AUTHOR), Vellone, V.5 (AUTHOR), Bersanelli, M.2 (AUTHOR), Maruzzo, M.6 (AUTHOR), Basso, U.6 (AUTHOR), Signori, A.7 (AUTHOR), Martelli, V.3 (AUTHOR), Catalano, F.3 (AUTHOR), Damassi, A.8 (AUTHOR), Murianni, V.3 (AUTHOR), Merler, S.4 (AUTHOR), Casartelli, C.2 (AUTHOR), Fornarini, G.9 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS607-S608. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152696599 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Brunelli%2C+M%2E%22">Brunelli, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buti%2C+S%2E%22">Buti, S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rebuzzi%2C+S%2EE%2E%22">Rebuzzi, S.E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Milella%2C+M%2E%22">Milella, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vellone%2C+V%2E%22">Vellone, V.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bersanelli%2C+M%2E%22">Bersanelli, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maruzzo%2C+M%2E%22">Maruzzo, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Basso%2C+U%2E%22">Basso, U.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Signori%2C+A%2E%22">Signori, A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martelli%2C+V%2E%22">Martelli, V.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Catalano%2C+F%2E%22">Catalano, F.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Damassi%2C+A%2E%22">Damassi, A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murianni%2C+V%2E%22">Murianni, V.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Merler%2C+S%2E%22">Merler, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Casartelli%2C+C%2E%22">Casartelli, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fornarini%2C+G%2E%22">Fornarini, G.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS607-S608. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152696599 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.2073 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S607 Titles: – TitleFull: 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brunelli, M. – PersonEntity: Name: NameFull: Buti, S. – PersonEntity: Name: NameFull: Rebuzzi, S.E. – PersonEntity: Name: NameFull: Milella, M. – PersonEntity: Name: NameFull: Vellone, V. – PersonEntity: Name: NameFull: Bersanelli, M. – PersonEntity: Name: NameFull: Maruzzo, M. – PersonEntity: Name: NameFull: Basso, U. – PersonEntity: Name: NameFull: Signori, A. – PersonEntity: Name: NameFull: Martelli, V. – PersonEntity: Name: NameFull: Catalano, F. – PersonEntity: Name: NameFull: Damassi, A. – PersonEntity: Name: NameFull: Murianni, V. – PersonEntity: Name: NameFull: Merler, S. – PersonEntity: Name: NameFull: Casartelli, C. – PersonEntity: Name: NameFull: Fornarini, G. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |